398 related articles for article (PubMed ID: 32664919)
1. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
Wang B; Van Oekelen O; Mouhieddine TH; Del Valle DM; Richter J; Cho HJ; Richard S; Chari A; Gnjatic S; Merad M; Jagannath S; Parekh S; Madduri D
J Hematol Oncol; 2020 Jul; 13(1):94. PubMed ID: 32664919
[TBL] [Abstract][Full Text] [Related]
2. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward.
Wang B; Van Oekelen O; Mouhieddine TH; Del Valle DM; Richter J; Cho HJ; Richard S; Chari A; Gnjatic S; Merad M; Jagannath S; Parekh S; Madduri D
medRxiv; 2020 Jun; ():. PubMed ID: 32577702
[TBL] [Abstract][Full Text] [Related]
3. New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.
Mani VR; Kalabin A; Valdivieso SC; Murray-Ramcharan M; Donaldson B
J Med Internet Res; 2020 Sep; 22(9):e20548. PubMed ID: 32540837
[TBL] [Abstract][Full Text] [Related]
4. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.
Kabarriti R; Brodin NP; Maron MI; Guha C; Kalnicki S; Garg MK; Racine AD
JAMA Netw Open; 2020 Sep; 3(9):e2019795. PubMed ID: 32975574
[TBL] [Abstract][Full Text] [Related]
5. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.
Richardson S; Hirsch JS; Narasimhan M; Crawford JM; McGinn T; Davidson KW; ; Barnaby DP; Becker LB; Chelico JD; Cohen SL; Cookingham J; Coppa K; Diefenbach MA; Dominello AJ; Duer-Hefele J; Falzon L; Gitlin J; Hajizadeh N; Harvin TG; Hirschwerk DA; Kim EJ; Kozel ZM; Marrast LM; Mogavero JN; Osorio GA; Qiu M; Zanos TP
JAMA; 2020 May; 323(20):2052-2059. PubMed ID: 32320003
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Mortality in Adults Admitted with COVID-19: Retrospective Cohort Study from New York City.
Chilimuri S; Sun H; Alemam A; Mantri N; Shehi E; Tejada J; Yugay A; Nayudu SK
West J Emerg Med; 2020 Jul; 21(4):779-784. PubMed ID: 32726241
[TBL] [Abstract][Full Text] [Related]
7. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.
Palaiodimos L; Kokkinidis DG; Li W; Karamanis D; Ognibene J; Arora S; Southern WN; Mantzoros CS
Metabolism; 2020 Jul; 108():154262. PubMed ID: 32422233
[TBL] [Abstract][Full Text] [Related]
8. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
9. Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications.
Zahid U; Ramachandran P; Spitalewitz S; Alasadi L; Chakraborti A; Azhar M; Mikhalina G; Sherazi A; Narh JT; Khattar P; Bedi P
Am J Nephrol; 2020; 51(10):786-796. PubMed ID: 33011717
[TBL] [Abstract][Full Text] [Related]
10. High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
Assaad S; Avrillon V; Fournier ML; Mastroianni B; Russias B; Swalduz A; Cassier P; Eberst L; Steineur MP; Kazes M; Perol M; Michallet AS; Rey P; Erena-Penet AS; Morel A; Brahmi M; Dufresne A; Tredan O; Chvetzoff G; Fayette J; de la Fouchardiere C; Ray-Coquard I; Bachelot T; Saintigny P; Tabutin M; Dupré A; Nicolas-Virelizier E; Belhabri A; Roux PE; Fuhrmann C; Pilleul F; Basle A; Bouhamama A; Galvez C; Herr AL; Gautier J; Chabaud S; Zrounba P; Perol D; Blay JY
Eur J Cancer; 2020 Aug; 135():251-259. PubMed ID: 32540204
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers.
Khoury R; Bernstein PS; Debolt C; Stone J; Sutton DM; Simpson LL; Limaye MA; Roman AS; Fazzari M; Penfield CA; Ferrara L; Lambert C; Nathan L; Wright R; Bianco A; Wagner B; Goffman D; Gyamfi-Bannerman C; Schweizer WE; Avila K; Khaksari B; Proehl M; Heitor F; Monro J; Keefe DL; D'Alton ME; Brodman M; Makhija SK; Dolan SM
Obstet Gynecol; 2020 Aug; 136(2):273-282. PubMed ID: 32555034
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
Petrilli CM; Jones SA; Yang J; Rajagopalan H; O'Donnell L; Chernyak Y; Tobin KA; Cerfolio RJ; Francois F; Horwitz LI
BMJ; 2020 May; 369():m1966. PubMed ID: 32444366
[TBL] [Abstract][Full Text] [Related]
13. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Zhou F; Yu T; Du R; Fan G; Liu Y; Liu Z; Xiang J; Wang Y; Song B; Gu X; Guan L; Wei Y; Li H; Wu X; Xu J; Tu S; Zhang Y; Chen H; Cao B
Lancet; 2020 Mar; 395(10229):1054-1062. PubMed ID: 32171076
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
Cummings MJ; Baldwin MR; Abrams D; Jacobson SD; Meyer BJ; Balough EM; Aaron JG; Claassen J; Rabbani LE; Hastie J; Hochman BR; Salazar-Schicchi J; Yip NH; Brodie D; O'Donnell MR
Lancet; 2020 Jun; 395(10239):1763-1770. PubMed ID: 32442528
[TBL] [Abstract][Full Text] [Related]
16. Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis.
Gregoriano C; Koch D; Haubitz S; Conen A; Fux CA; Mueller B; Bernasconi L; Hammerer-Lercher A; Oberle M; Burgermeister S; Reiter H; Kutz A; Schuetz P
Swiss Med Wkly; 2020 Jul; 150():w20316. PubMed ID: 32668007
[TBL] [Abstract][Full Text] [Related]
17. CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY.
Ortiz-Brizuela E; Villanueva-Reza M; González-Lara MF; Tamez-Torres KM; Román-Montes CM; Díaz-Mejía BA; Pérez-García E; Olivas-Martínez A; Rajme-López S; Martinez-Guerra BA; de-León-Cividanes NA; Fernández-García OA; Guerrero-Torres L; Torres-González L; Carrera-Patiño FA; Corral-Herrera EA; Hernández-Alemón AN; Tovar-Vargas MLÁ; Serrano-Pinto YG; Espejo-Ortiz CE; Morales-Ortega ML; Lozano-Cruz ÓA; Cárdenas-Fragoso JL; Vidal-Mayo JJ; Hernández-Gilsoul T; Rivero-Sigarroa E; Domínguez-Cherit G; Cervantes-Villar LE; Ramos-Cervantes MDP; Ibarra-González V; Calva-Mercado JJ; Sierra-Madero JG; López-Íñiguez Á; Ochoa-Hein E; Crabtree-Ramírez BE; Galindo-Fraga A; Guerrero-Almeida ML; Ruiz-Palacios GM; Gulías-Herrero A; Sifuentes-Osornio J; Kershenobich-Stalnikowitz D; Ponce-de-León A
Rev Invest Clin; 2020; 72(3):165-177. PubMed ID: 32584326
[TBL] [Abstract][Full Text] [Related]
18. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
19. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.
Argenziano MG; Bruce SL; Slater CL; Tiao JR; Baldwin MR; Barr RG; Chang BP; Chau KH; Choi JJ; Gavin N; Goyal P; Mills AM; Patel AA; Romney MS; Safford MM; Schluger NW; Sengupta S; Sobieszczyk ME; Zucker JE; Asadourian PA; Bell FM; Boyd R; Cohen MF; Colquhoun MI; Colville LA; de Jonge JH; Dershowitz LB; Dey SA; Eiseman KA; Girvin ZP; Goni DT; Harb AA; Herzik N; Householder S; Karaaslan LE; Lee H; Lieberman E; Ling A; Lu R; Shou AY; Sisti AC; Snow ZE; Sperring CP; Xiong Y; Zhou HW; Natarajan K; Hripcsak G; Chen R
BMJ; 2020 May; 369():m1996. PubMed ID: 32471884
[TBL] [Abstract][Full Text] [Related]
20. Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.
Luetkens T; Metcalf R; Planelles V; Zheng Y; Larragoite ET; Spivak ES; Spivak AM; Steinbach M; Blaylock RC; Avila SV; Hankey KG; Martins TB; Slev PR; Mannuel HD; Sajadi M; Rapoport AP; Atanackovic D
Blood Adv; 2020 Oct; 4(19):4864-4868. PubMed ID: 33031540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
